Literature DB >> 3619428

Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics.

C L Gaudreau, L A Lariviere, J C Lauzer, F F Turgeon.   

Abstract

The effect of clavulanic acid on the susceptibility of 32 strains of Campylobacter jejuni and Campylobacter coli to eight beta-lactam agents was studied. Almost all strains tested became susceptible to amoxicillin and ticarcillin with 1 microgram of clavulanic acid per ml. This compound had little or no effect on susceptibility to penicillin G, cephalothin, cefamandole, and cefoxitin. Clavulanic acid had a marginal effect on cefotaxime and moxalactam susceptibility.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619428      PMCID: PMC284216          DOI: 10.1128/AAC.31.6.940

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  [Campylobacter and enteritis].

Authors:  W P Severin
Journal:  Ned Tijdschr Geneeskd       Date:  1978-04-15

2.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

3.  Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates.

Authors:  M A Karmali; S De Grandis; P C Fleming
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam.

Authors:  P Van der Auwera; B Scorneaux
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

5.  In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.

Authors:  V I Ahonkhai; C E Cherubin; M F Sierra; V D Bokkenheuser; M A Shulman; A C Mosenthal
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

  5 in total
  7 in total

1.  In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.

Authors:  P Hohl; J Zollinger-Iten; A von Graevenitz
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 2.  Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  P A Todd; P Benfield
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

3.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.

Authors:  P Tajada; J L Gomez-Graces; J I Alós; D Balas; R Cogollos
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

5.  Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; F Turgeon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

6.  Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents.

Authors:  N Lachance; C Gaudreau; F Lamothe; L A Larivière
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

7.  Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

Authors:  R Shawar; M LaRocco; T G Cleary
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.